Amarillo Biosciences Inc (AMAR) financial statements (2021 and earlier)

Company profile

Business Address AMARILLO BIOSCIENCES INC
AMARILLO, TX 79110-4225
State of Incorp. TX
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments224091,2771,980134 250
Cash and cash equivalents224091,2771,980134 250
Receivables   5838  
Inventory, net of allowances, customer advances and progress billings34 2315  
Inventory34 2315  
Other undisclosed current assets5132272476  
Total current assets:764451,3032,084262 250
Noncurrent Assets
Property, plant and equipment35142744  
Intangible assets, net (including goodwill)181146146182156  
Intangible assets, net (excluding goodwill)181146146182156  
Total noncurrent assets:184151160209200  
TOTAL ASSETS:2605971,4642,294463 250
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:146209115159166  
Other undisclosed accounts payable and accrued liabilities146209115159166  
Debt953      
Due to related parties 100105777188  
Other undisclosed current liabilities 445513886920  
Total current liabilities:1,0997537341,8231,273  
Noncurrent Liabilities
Other undisclosed liabilities      452
Total liabilities:1,0997537341,8231,273 452
Stockholders' equity
Stockholders' equity attributable to parent(838)(157)730471(810)  
Common stock421405391232219  
Additional paid in capital4,9614,2083,5272,123238  
Accumulated deficit(6,220)(4,770)(3,188)(1,884)(1,267)  
Total stockholders' equity:(838)(157)730471(810)  
TOTAL LIABILITIES AND EQUITY:2605971,4642,294463 452

Income statement (P&L) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues171278251 2 
Revenue, net  2 
Cost of revenue(11)(9)(65)(60)  (0)
Cost of goods and services sold      (0)
Gross profit:5313191 2(0)
Operating expenses(1,446)(1,583)(1,348)(580)(667)(32)(1)
Other undisclosed operating loss   (191)   
Operating loss:(1,440)(1,580)(1,335)(580)(667)(30)(1)
Interest and debt expense(10) (4)(38)(3)  
Net loss:(1,450)(1,580)(1,339)(617)(670)(30)(1)
Other undisclosed net loss attributable to parent(0)(1)     
Net loss available to common stockholders, diluted:(1,451)(1,581)(1,339)(617)(670)(30)(1)

Comprehensive Income ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(1,450)(1,580)(1,339)(617)(670)(30)(1)
Comprehensive loss, net of tax, attributable to parent:(1,450)(1,580)(1,339)(617)(670)(30)(1)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: